Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register-based drug utilization study

Lotte Rasmussen; Jacob Harbo Andersen; Øystein Karlstad; Diego Hernan Giunta; Marie Linder; Kari Furu; Anton Pottegård

doi:10.1111/dom.15876

Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register-based drug utilization study

Lotte Rasmussen, Jacob Harbo Andersen, Øystein Karlstad, Diego Hernan Giunta, Marie Linder, Kari Furu, Anton Pottegård^*

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Diabetes, Obesity and Metabolism
Vol/bind	26
Udgave nummer	11
Sider (fra-til)	5479-5482
ISSN	1462-8902
DOI	https://doi.org/10.1111/dom.15876
Status	Udgivet - nov. 2024

Dokumenter og links

10.1111/dom.15876Licens: CC BY-NC

Open Access VersionForlagets udgivne version, 598 KBLicens: CC BY-NC

Citationsformater

@article{c28f3b16cde74b0f9ac36965cd54e553,

title = "Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register-based drug utilization study",

keywords = "antidiabetic drug, database research, liraglutide, pharmaco-epidemiology, semaglutide, Humans, Middle Aged, Male, Drug Utilization/statistics & numerical data, Scandinavian and Nordic Countries/epidemiology, Denmark/epidemiology, Diabetes Mellitus, Type 2/drug therapy, Glucagon-Like Peptides/therapeutic use, Female, Hypoglycemic Agents/therapeutic use, Registries, Adult, Aged",

author = "Lotte Rasmussen and Andersen, {Jacob Harbo} and {\O}ystein Karlstad and Giunta, {Diego Hernan} and Marie Linder and Kari Furu and Anton Potteg{\aa}rd",

year = "2024",

month = nov,

doi = "10.1111/dom.15876",

language = "English",

volume = "26",

pages = "5479--5482",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley",

number = "11",

}

Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register-based drug utilization study. / Rasmussen, Lotte ; Andersen, Jacob Harbo; Karlstad, Øystein et al.
I: Diabetes, Obesity and Metabolism, Bind 26, Nr. 11, 11.2024, s. 5479-5482.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark

T2 - A register-based drug utilization study

AU - Rasmussen, Lotte

AU - Andersen, Jacob Harbo

AU - Karlstad, Øystein

AU - Giunta, Diego Hernan

AU - Linder, Marie

AU - Furu, Kari

AU - Pottegård, Anton

PY - 2024/11

Y1 - 2024/11

KW - antidiabetic drug

KW - database research

KW - liraglutide

KW - pharmaco-epidemiology

KW - semaglutide

KW - Humans

KW - Middle Aged

KW - Male

KW - Drug Utilization/statistics & numerical data

KW - Scandinavian and Nordic Countries/epidemiology

KW - Denmark/epidemiology

KW - Diabetes Mellitus, Type 2/drug therapy

KW - Glucagon-Like Peptides/therapeutic use

KW - Female

KW - Hypoglycemic Agents/therapeutic use

KW - Registries

KW - Adult

KW - Aged

U2 - 10.1111/dom.15876

DO - 10.1111/dom.15876

M3 - Journal article

C2 - 39164856

AN - SCOPUS:85201613098

SN - 1462-8902

VL - 26

SP - 5479

EP - 5482

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 11

ER -